Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
space)? What are appropriate descriptors of spatial distribution in the field of materials science (e.g., Voronoi tessellations, particle-particle distances, etc.)? What are appropriate algorithms
-
the research and education has a unique breadth, with large activities in classical scientific computing areas such as mathematical modeling, development and analysis of algorithms, scientific software
-
data for urban characterization. The work includes developing algorithms, performing large-scale analyses, and collaborating with partners across disciplines in remote sensing, urban studies, and climate
-
focuses on combining novel genome engineering tools (e.g., CRISPR-based) and computational algorithms to enable regenerative cell therapies. Now, we are seeking a highly driven postdoctoral researcher
-
writing scientific papers and communicating our research advances in conferences. Methods: programming a humanoid platform using ROS2 packages, solve SLAM, use imitation learning algorithms to learn pick
-
AI methods and genetic algorithms Prior publication experience at top robotics and AI conferences (ICRA/IROS*/RSS/NIPS/CoRL) / journals (RAL/TRO/IJRR/RAM) is necessary *If you are attending IROS 2025
-
properties. In this project, we will apply machine learning and optimization algorithms in order to achieve the design of such nanophotonic structures. As a postdoc you will be part of the Condensed Matter and
-
apply machine learning and optimization algorithms in order to achieve the design of such nanophotonic structures. As a postdoc you will be part of the Condensed Matter and Materials Theory division, a
-
analysis of complex, longitudinal, and high-dimensional data (e.g., immunometabolic profiles, clinical data, biomarkers). Development and application of predictive models and algorithms for diagnostics
-
setting. In this environment, our research group focuses on combining novel genome engineering tools (e.g., CRISPR-based) and computational algorithms to enable regenerative cell therapies. Now, we are